Evidence map›Paper›PMID 36171729›Full record

ArticleThe Journal of international medical research2022

Identification of

Enty Tjoa, Shikha Joon, Lucky Hartati Moehario, Luse Loe, Franz J V Pangalila

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of international medical research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Enty TjoaDepartment of Microbiology, School of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia.ORCID 0000-0001-7187-4280
Shikha JoonSchool of Biotechnology, Jawaharlal Nehru University, New Delhi, India.
Lucky Hartati MoeharioDepartment of Microbiology, School of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia.
Luse LoeDepartment of Internal Medicine, School of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia.
Franz J V PangalilaInternal Medicine Department, Faculty of Medicine, Universitas Tarumanagara (UNTAR), Jakarta, Indonesia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesCommunity-acquired pneumonia (CAP) is a global health condition that affects populations from all age groups. The laboratory identification of

methodsThis prospective study used a cross-sectional approach to assess the diagnostic potential of PneumoCLART bacteria® for detecting

resultsThe PneumoCLART bacteria® results illustrated that 7 of 27 patients with pneumonia were positive for

conclusionsBecause the leukocyte count was low and sputum specimens were saliva-contaminated, these findings require further validation to prove the utility of CLART® microarray technology for the identification of

Indexed as

Community-Acquired InfectionsPneumoniaPneumonia, MycoplasmaAdultBacteriaHumansMycoplasma pneumoniaeProspective StudiesTechnologyCLART® microarray technologyCommunity-acquired pneumoniahospitalizationMycoplasma pneumoniaePneumoCLART bacteria®saliva contaminationsputum

Identifiers

PMID36171729
PMCPMC9523878

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.